Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells - PubMed (original) (raw)
. 2001 Oct 26;276(43):39990-40000.
doi: 10.1074/jbc.M103181200. Epub 2001 Aug 16.
Affiliations
- PMID: 11509559
- DOI: 10.1074/jbc.M103181200
Free article
Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells
J Worm et al. J Biol Chem. 2001.
Free article
Abstract
The molecular basis of methotrexate resistance was studied in human MDA-MB-231 breast cancer cells, which are inherently defective in methotrexate uptake and lack expression of the reduced folate carrier (RFC). Transfection of MDA-MB-231 cells with RFC cDNA restored methotrexate uptake and increased methotrexate sensitivity by approximately 50-fold. A CpG island in the promoter region of RFC was found to be methylated in MDA-MB-231 cells, but was unmethylated in RFC expressing, methotrexate-sensitive MCF-7 breast cancer cells. Chromatin immunoprecipitation with antibodies against acetylated histones H3 and H4 showed that the RFC promoter was enriched for acetylated histones on expressed, unmethylated alleles only. Treatment of MDA-MB-231 cells with 5-aza-2'-deoxycytidine restored RFC expression but also led to increased methotrexate efflux and did not reverse methotrexate resistance. This suggests that 5-aza-2'-deoxycytidine up-regulates both methotrexate uptake and some methotrexate-resistance mechanism(s). Reverse transcription-polymerase chain reaction analysis showed increased expression levels of several ATP-dependent efflux pumps in response to 5-aza-2'-deoxycytidine treatment, including P-glycoprotein and members of the multidrug resistance-associated protein family. Up-regulation of P-glycoprotein in response to 5-aza-2'-deoxycytidine was associated with demethylation of a CpG island in the MDR1 promoter, whereas the mechanism(s) for 5-aza-2'-deoxycytidine-induced up-regulation of multidrug resistance-associated proteins is probably indirect. Dipyridamole inhibited methotrexate efflux and reversed methotrexate resistance in 5-aza-2'-deoxycytidine-treated MDA-MB-231 cells.
Similar articles
- Association of deletions and translocation of the reduced folate carrier gene with profound loss of gene expression in methotrexate-resistant K562 human erythroleukemia cells.
Ding BC, Witt TL, Hukku B, Heng H, Zhang L, Matherly LH. Ding BC, et al. Biochem Pharmacol. 2001 Mar 15;61(6):665-75. doi: 10.1016/s0006-2952(01)00535-4. Biochem Pharmacol. 2001. PMID: 11266651 - MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine.
David GL, Yegnasubramanian S, Kumar A, Marchi VL, De Marzo AM, Lin X, Nelson WG. David GL, et al. Cancer Biol Ther. 2004 Jun;3(6):540-8. doi: 10.4161/cbt.3.6.845. Epub 2004 Jun 10. Cancer Biol Ther. 2004. PMID: 15034303 - Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells.
Jansen G, Mauritz RM, Assaraf YG, Sprecher H, Drori S, Kathmann I, Westerhof GR, Priest DG, Bunni M, Pinedo HM, Schornagel JH, Peters GJ. Jansen G, et al. Adv Enzyme Regul. 1997;37:59-76. doi: 10.1016/s0065-2571(96)00012-x. Adv Enzyme Regul. 1997. PMID: 9381986 - Reduced folate carrier: biochemistry and molecular biology of the normal and methotrexate-resistant cell.
Bosson G. Bosson G. Br J Biomed Sci. 2003;60(2):117-29. doi: 10.1080/09674845.2003.11783687. Br J Biomed Sci. 2003. PMID: 12866924 Review. - Methotrexate transport and resistance.
Moscow JA. Moscow JA. Leuk Lymphoma. 1998 Jul;30(3-4):215-24. doi: 10.3109/10428199809057535. Leuk Lymphoma. 1998. PMID: 9713954 Review.
Cited by
- Induction of Drug-Resistance and Production of a Culture Medium Able to Induce Drug-Resistance in Vinblastine Untreated Murine Myeloma Cells.
Masci VL, Stefanoni D, D'Alessandro A, Zambelli M, Modesti L, Pollini D, Ovidi E, Tiezzi A. Masci VL, et al. Molecules. 2023 Feb 22;28(5):2051. doi: 10.3390/molecules28052051. Molecules. 2023. PMID: 36903299 Free PMC article. - Methotrexate promotes glucose uptake and lipid oxidation in skeletal muscle via AMPK activation.
Pirkmajer S, Kulkarni SS, Tom RZ, Ross FA, Hawley SA, Hardie DG, Zierath JR, Chibalin AV. Pirkmajer S, et al. Diabetes. 2015 Feb;64(2):360-9. doi: 10.2337/db14-0508. Epub 2014 Oct 22. Diabetes. 2015. PMID: 25338814 Free PMC article. - Epigenetic diagnostics of cancer--the application of DNA methylation markers.
Paluszczak J, Baer-Dubowska W. Paluszczak J, et al. J Appl Genet. 2006;47(4):365-75. doi: 10.1007/BF03194647. J Appl Genet. 2006. PMID: 17132902 Review. - Pharmacogenetics and pharmacoepigenetics of gemcitabine.
Candelaria M, de la Cruz-Hernández E, Pérez-Cárdenas E, Trejo-Becerril C, Gutiérrez-Hernández O, Dueñas-González A. Candelaria M, et al. Med Oncol. 2010 Dec;27(4):1133-43. doi: 10.1007/s12032-009-9349-y. Epub 2009 Nov 10. Med Oncol. 2010. PMID: 19902390 Review. - Determinants of orofacial clefting II: Effects of 5-Aza-2'-deoxycytidine on gene methylation during development of the first branchial arch.
Seelan RS, Mukhopadhyay P, Warner DR, Smolenkova IA, Pisano MM, Greene RM. Seelan RS, et al. Reprod Toxicol. 2017 Jan;67:100-110. doi: 10.1016/j.reprotox.2016.11.020. Epub 2016 Dec 5. Reprod Toxicol. 2017. PMID: 27923600 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous